SRIM
CL icon

Saratoga Research & Investment Management’s Colgate-Palmolive CL Stock Holding History

Saratoga Research & Investment Management’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1M Sell
175,603
-14,492
-8% -$1.27M 0.88% 26
2026
Q1 		$16.2M Buy
190,095
+3,532
+2% +$315K 0.92% 26
2025
Q4 		$14.7M Sell
186,563
-7,532
-4% -$591K 0.77% 28
2025
Q3 		$15.5M Sell
194,095
-1,601
-0.8% -$137K 0.81% 29
2025
Q2 		$17.8M Buy
195,696
+2,140
+1% +$195K 0.95% 26
2025
Q1 		$18.1M Buy
193,556
+67,089
+53% +$6.01M 0.96% 28
2024
Q4 		$11.5M Sell
126,467
-8,477
-6% -$809K 0.58% 29
2024
Q3 		$14M Sell
134,944
-10,390
-7% -$1.06M 0.61% 29
2024
Q2 		$14.1M Sell
145,334
-10,060
-6% -$928K 0.64% 29
2024
Q1 		$14M Sell
155,394
-4,093
-3% -$347K 0.64% 29
2023
Q4 		$12.7M Sell
159,487
-3
-0% -$226 0.59% 31
2023
Q3 		$11.3M Buy
159,490
+11,820
+8% +$884K 0.55% 30
2023
Q2 		$11.4M Sell
147,670
-5,284
-3% -$409K 0.52% 31
2023
Q1 		$11.5M Buy
152,954
+110,479
+260% +$8.22M 0.55% 31
2022
Q4 		$3.35M Buy
42,475
+38,717
+1,030% +$2.9M 0.17% 34
2022
Q3 		$264K Sell
3,758
-4,557
-55% -$357K 0.01% 42
2022
Q2 		$666K Buy
8,315
+1
+0% +$78 0.03% 36
2022
Q1 		$630K Buy
8,314
+957
+13% +$75.8K 0.03% 36
2021
Q4 		$628K Buy
7,357
+2,057
+39% +$161K 0.03% 37
2021
Q3 		$401K Buy
+5,300
New +$421K 0.02% 36
2018
Q2 		– Sell
-3,393
Closed -$243K – 46
2018
Q1 		$243K Buy
3,393
+25
+0.7% +$1.8K 0.02% 42
2017
Q4 		$254K Hold
3,368
– – 0.02% 43
2017
Q3 		$245K Buy
3,368
+40
+1% +$2.88K 0.02% 43
2017
Q2 		$247K Buy
+3,328
New +$247K 0.02% 43
2016
Q3 		– Sell
-72,267
Closed -$5.29M – 46
2016
Q2 		$5.29M Sell
72,267
-2,690
-4% -$192K 0.47% 29
2016
Q1 		$5.3M Sell
74,957
-5,070
-6% -$337K 0.47% 32
2015
Q4 		$5.33M Sell
80,027
-2,293
-3% -$153K 0.52% 33
2015
Q3 		$5.22M Sell
82,320
-13,169
-14% -$860K 0.52% 33
2015
Q2 		$6.25M Sell
95,489
-4,393
-4% -$298K 0.59% 34
2015
Q1 		$6.93M Sell
99,882
-2,300
-2% -$159K 0.65% 33
2014
Q4 		$7.07M Buy
102,182
+1,800
+2% +$122K 0.65% 33
2014
Q3 		$6.55M Sell
100,382
-2,739
-3% -$181K 0.65% 33
2014
Q2 		$7.03M Sell
103,121
-5,051
-5% -$339K 0.7% 32
2014
Q1 		$7.02M Sell
108,172
-1,529
-1% -$96.4K 0.72% 33
2013
Q4 		$7.15M Sell
109,701
-2,042
-2% -$131K 0.76% 33
2013
Q3 		$6.63M Sell
111,743
-3,170
-3% -$188K 0.78% 33
2013
Q2 		$6.58M Buy
+114,913
New +$6.82M 0.77% 33

Other funds holding CL

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Saratoga Research & Investment Management's CL Position: Q2 2026 in Review

Saratoga Research & Investment Management reduced its Colgate-Palmolive (CL) stake by 7.6% in Q2 2026, selling an estimated $1.27M and leaving 175,603 shares worth $16.1M. The position accounts for 0.88% of the portfolio, ranked #26.

Saratoga Research & Investment Management first reported a position in CL in Q2 2013 and has held it in 37 quarters since. The position peaked at $18.1M in Q1 2025. 1,006 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Saratoga Research & Investment Management held 175,603 shares of Colgate-Palmolive worth $16.1M as of Q2 2026.
  • Saratoga Research & Investment Management sold 14,492 Colgate-Palmolive shares in Q2 2026, an estimated $1.27M.
  • Colgate-Palmolive made up 0.88% of Saratoga Research & Investment Management's portfolio in Q2 2026, its #26 holding.
  • Saratoga Research & Investment Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 37 quarters since.
  • Saratoga Research & Investment Management's Colgate-Palmolive position peaked at $18.1M in Q1 2025.
  • 1,006 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Saratoga Research & Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.